Exozymes (EXOZ) Change in Taxes (2024)
Exozymes (EXOZ) posted quarterly Change in Taxes of -$40924.0 for Q2 2024, down 2947.21% quarter-over-quarter from -$1343.0 in Q1 2024.
Exozymes (EXOZ) Change in Taxes (2024) Analysis & Trends
Exozymes (EXOZ) has reported Change in Taxes for 1 consecutive years, with -$40924.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Change in Taxes changed N/A year-over-year to -$40924.0; the TTM figure through Dec 2024 stood at -$42267.0 (changed N/A YoY), while the FY2024 annual figure was -$42267.0, down 98.51% from the prior year.
- Change in Taxes fell to -$40924.0 in Q2 2024 per EXOZ's latest filing, from -$1343.0 in the prior quarter.
- Across five years, Change in Taxes topped out at -$1343.0 in Q1 2024 and bottomed at -$40924.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -40,924.00 |
| Jun 30, 2024 | -40,924.00 |
| Mar 31, 2024 | -1,343.00 |
| Mar 31, 2024 | -1,343.00 |